The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma

W Wang, Z Lu, M Wang, Z Liu, B Wu, C Yang… - Frontiers in …, 2022 - frontiersin.org
Background Copper ions are essential for cellular physiology. Cuproptosis is a novel
method of copper-dependent cell death, and the cuproptosis-based signature for glioma …

Molecular biomarker testing for the diagnosis of diffuse gliomas: guideline from the College of American Pathologists in collaboration with the American Association of …

DJ Brat, K Aldape, JA Bridge… - … of pathology & …, 2022 - meridian.allenpress.com
Context.—The diagnosis and clinical management of patients with diffuse gliomas (DGs)
have evolved rapidly over the past decade with the emergence of molecular biomarkers that …

Glioblastoma therapy: rationale for a mesenchymal stem cell-based vehicle to carry recombinant viruses

S Ali, Q Xia, T Muhammad, L Liu, X Meng… - Stem Cell Reviews and …, 2021 - Springer
Evasion of growth suppression is among the prominent hallmarks of cancer. Phosphatase
and tensin homolog (PTEN) and p53 tumor-suppressive pathways are compromised in most …

Copy number variation and rearrangements assessment in cancer: comparison of droplet digital PCR with the current approaches

VY Cusenza, A Bisagni, M Rinaldini, C Cattani… - International Journal of …, 2021 - mdpi.com
The cytogenetic and molecular assessment of deletions, amplifications and rearrangements
are key aspects in the diagnosis and therapy of cancer. Not only the initial evaluation and …

Brain-targeted antigen-generating nanoparticles improve glioblastoma prognosis

W Wang, M Zhang, Q Zhang, M Mohammadniaei… - Journal of Controlled …, 2022 - Elsevier
The exploration of multifunctional nanomedicine has prompted interest in improving
glioblastoma (GBM) prognosis. In this study, we constructed tumor microenvironment (TME) …

Genomic landscape of gliosarcoma: distinguishing features and targetable alterations

MM Zaki, LA Mashouf, E Woodward, P Langat… - Scientific Reports, 2021 - nature.com
Gliosarcoma is an aggressive brain tumor with histologic features of glioblastoma (GBM)
and soft tissue sarcoma. Despite its poor prognosis, its rarity has precluded analysis of its …

Identification of genes related to low‐grade glioma progression and prognosis based on integrated transcriptome analysis

Y Jiang, J He, Y Guo, H Tao, F Pu… - Journal of cellular …, 2020 - Wiley Online Library
Glioma is one of the most common types of human brain tumor, with high mortality in high‐
grade gliomas (HGG). Low‐grade gliomas (LGG) can progress into HGG, leading to poor …

Role of CDKN2A deletion in grade 2/3 IDH-mutant astrocytomas: need for selective approach in resource-constrained settings

S Suman, R Sharma, V Katiyar, S Mahajan, A Suri… - Neurosurgical …, 2022 - thejns.org
OBJECTIVE The authors aimed to assess the frequency of homozygous CDKN2A deletion
in isocitrate dehydrogenase (IDH)–mutant diffuse astrocytomas (grade 2/3) and to narrow …

Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration

D Cai, X Ma, H Guo, H Zhang, A Bian, H Yu… - Journal of Orthopaedic …, 2022 - Springer
Abstract Background p16, p53, and proliferating cell nuclear antigen (pcna) genes play
significant roles in many chromatin modifications and have been found to be highly …

Prognostic factors of low-grade gliomas in adults

M Deacu, S Popescu, A Docu Axelerad… - Current …, 2022 - mdpi.com
Adult low-grade gliomas are a rare and aggressive pathology of the central nervous system.
Some of their characteristics contribute to the patient's life expectancy and to their …